DUBLIN--(BUSINESS WIRE)--Nov. 29, 2011--
Alkermes
plc (NASDAQ: ALKS) announced today that its corporate presentation
will be webcast live at the NASDAQ OMX 27th Investor Program
on Tuesday, December 6, 2011, at 1:15 p.m. GMT (8:15 a.m. ET) from the
Chancery Court Hotel in London. The presentation may be accessed from
the investor relations section on www.alkermes.com
and will be archived for 14 days.
Alkermes plc is a fully integrated, global biopharmaceutical company
that applies its scientific expertise and proprietary technologies to
develop innovative medicines that improve patient outcomes. The company
has a diversified portfolio of more than 20 commercial drug products and
a substantial clinical pipeline of product candidates that address
central nervous system (CNS) disorders such as addiction, schizophrenia
and depression. Headquartered in Dublin, Ireland, Alkermes plc has an
R&D center in Waltham, Massachusetts and manufacturing facilities in
Athlone, Ireland; Gainesville, Georgia; and Wilmington, Ohio. For more
information, please visit Alkermes’ website at www.alkermes.com.
Source: Alkermes plc
Alkermes plc
Eva Stroynowski, +1-781-609-6823
Corporate
Communications
